FIGURE

Fig. 4

ID
ZDB-FIG-231208-19
Publication
Dogra et al., 2023 - kcna1a mutant zebrafish model episodic ataxia type 1 (EA1) with epilepsy and respond to first-line therapy carbamazepine
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4

Brain hyperexcitability and E/I imbalance analysis in kcna1a−/− zebrafish. (A, B, B′) Representative extracellular field recordings obtained from the optic tectum of 3 dpf WT (A) and kcna1a−/− zebrafish larvae (B, B′- higher magnification of B). WTs show no evidence of abnormal electrical activity. The repetitive inter-ictal like discharges with high-frequency large amplitude spikes (1.6 ± 0.5 Hz; 0.4 ± 0.1 mV) seen in the kcna1a−/− are indicative of increased network hyperexcitability. WT, n = 7 out of 7 with no abnormal activity; kcna1a−/−, n = 5 out of 8 show epileptiform activity. (C, D) Representative extracellular recordings obtained from optic tectum of 3 dpf kcna1a−/− zebrafish larvae before (C) and after treatment with carbamazepine (D). Carbamazepine treatment leads to the reversal of epileptiform activity of kcna1a−/−. kcna1a−/−, n = 3 out of 3 have their hyperexcitability rescued by carbamazepine. (E–G) qPCR analysis for relative fosab, vglut2a, and gad1b mRNA expression in 3 dpf and 5 dpf kcna1a−/− larvae compared to WT. WT and kcna1a−/−, n = 3 × 10 larvae assessed as three biological and two technical replicates each. fosab is upregulated in kcna1a−/− indicating brain hyperexcitability. vglut2a is upregulated and gad1b is downregulated in kcna1a−/− indicating dysfunctional E/I balance. Data are mean ± SEM, ns: no significant changes observed, *p ≤ .05, **p ≤ .01- Unpaired t test.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Epilepsia